Creative Biolabs has expanded its advanced single-cell multi-omics and RNA sequencing solutions, aiming to support biomedical discovery by providing high-resolution cellular profiling for global researchers. The upgraded suite offers end-to-end services, from single-cell transcriptome profiling to integrated multimodal and multi-omics workflows, addressing the growing demand for detailed cellular analysis in oncology, immunology, and neuroscience.
The expansion comes as life science research increasingly shifts from bulk tissue profiling to single-cell resolution. This transition is critical for identifying rare cell subpopulations, characterizing complex tumor microenvironments, and tracing cell lineage trajectories. Creative Biolabs now delivers robust, high-throughput single-cell RNA sequencing services that provide high sensitivity and coverage across thousands of individual cells, yielding high-resolution transcriptomic insights from diverse fresh biological specimens.
To address the challenge of processing complex, fibrous, or biobanked archival samples, the platform includes specialized single-nucleus RNA sequencing (snRNA-seq) capabilities. For tissues where single-cell dissociation can cause cell damage, stress responses, or loss of fragile cell types—such as human brain, myocardium, or flash-frozen clinical biopsies—Creative Biolabs offers an optimized single-cell nuclei RNA sequencing service. By isolating intact nuclei, this approach bypasses harsh enzymatic dissociation and minimizes artifacts while retaining informative nuclear RNA profiles, expanding the scope of clinical translational research.
Recognizing that cellular identity is regulated across multiple layers, Creative Biolabs also advances its high-throughput single-cell multi-omics service. This integrated platform enables simultaneous interrogation of genomic variations, epigenomic landscapes such as chromatin accessibility, cell surface proteomics (CITE-seq), and transcriptomes within identical single cells. By linking epigenetic regulation and genomic alterations to gene expression readouts, the service allows researchers to construct multi-dimensional cellular atlases and uncover novel therapeutic targets with greater biological clarity.
"Understanding biology at single-cell and single-nucleus resolution is no longer a luxury—it is fundamental to precision medicine and biomarker discovery," said a senior scientist at Creative Biolabs. "Our goal is to provide researchers with a seamless, modular analytical ecosystem that transforms difficult biological samples into reliable, high-dimensional datasets with rigorous bioinformatics support."
Supported by advanced microfluidics technologies, stringent quality control benchmarks, and tailored bioinformatics pipelines, Creative Biolabs continues to partner with academic and biopharmaceutical research teams worldwide to unravel the complexities of human disease. This expansion matters because it directly addresses persistent bottlenecks in single-cell research, such as sample degradation and the need for integrated multi-omic data. By making it easier to analyze challenging samples and combine multiple data types, the services could accelerate target validation, immunology profiling, and translational drug development, ultimately bringing researchers closer to precision therapies.
